1st Quarter - Report

AMERICA'S HEALTH INSURANCE PLANS, INC. (AHIP) for AMERICA'S HEALTH INSURANCE PLANS INC (AHIP)

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
—
Expenses
$2,330,000
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
1st Quarter - Report (this page) Apr 20, 2011 $2,330,000 Replaced
1st Quarter - Amendment Oct 25, 2011 $2,330,000 Replaced
1st Quarter - Amendment Apr 20, 2012 $2,430,000 Yes

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

H.R.369, Health Savings and Affordability Act (Austria) HSA improvements; H.R. 450, Restoring Assistance for Families' and Seniors' Health Expenses Act (Reichert) repeal of HSA and FSA restrictions (cont.) H.R. 524, Restoring Consumer-driven Health Care Act (Quayle) repeal of HSA restrictionsl; H.R. 605, Patients' Freedom to Choose Act (Paulsen) repeal of HSA and FSA restrictions; S. 312, Patients' Freedom to Choose Act (Hutchison) repeal of HSA and FSA restrictions TAX (Regulatory) Issues relating to Health Savings Accounts; issues regarding payment for OTC drugs from a health account; issues regarding deduction for remuneration for insurance services; issues concerning small employer tax credits and retiree coverage reinsurance; issues regarding application of the nondiscrimination rules to insured group health coverage; issues relating to withholding of government contract payments; pre-existing condition insurance plans, internal claims and appeals and external review processes, coverage of preventive services; pre-existing condition exclusions, lifetime and annual dollar limits on benefits, rescissions, and patient protections; grandfathered health plan provisions; dependent coverage; issues relating to IRC Sec 162(m) reporting; issues relating to the annual fee on health insurance providers; employer reporting of health coverage; determination of COBRA premium values; and other issues relating to health care reform implementation.

LobbyistCovered position, as disclosed
JEREMY ALLEN New Rep. Bilirakis stf 3/02-6/03, H. E&C stf 6/03-7/04
SUSAN CORONEL —
KAREN IGNAGNI —
ALETHIA JACKSON —
ERIK KOMENDANT New —
SCOTT STYLES —
KELLY RENEA VOGEL —
THOMAS JEROME WILDER —

Contacted: SENATE; Social Security Administration (SSA); Agency for Healthcare Research & Quality (AHRQ); Executive Office of the President (EOP); Office of Personnel Management (OPM); Centers For Medicare and Medicaid Services (CMS); Drug Enforcement Administration (DEA); HOUSE OF REPRESENTATIVES; Medicare Payment Advisory Commission (MedPAC); Labor, Dept of (DOL); Federal Trade Commission (FTC); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); Internal Revenue Service (IRS); Treasury, Dept of

Bills named: H.R. 605 (112th), H.R. 524 (112th), S. 312 (112th), H.R. 450 (112th), H.R. 369 (112th)

Health Issues HCR

H.J.Res 44, Continuing Resolution (Rogers) funding for HHS programs and agencies; H.J.Res 48, Continuing Resolution (Rogers) funding for HHS programs and agencies (cont.) H.R. 1, Full-Year Continuing Appropriations Act (Rogers) funding for HHS programs and agencies; H.R. 4, 1099 Taxpayer Protection and Repayment of Exchange Subsidy Overpayments Act (Lungren) repeal of Form 1099 provision; H.R. 5, HEALTH Act (Gingrey) medical liability reform; H.R.611 -- BEST PRACTICES Act (Rush) data security; S. 18, Small Business Paperwork Mandate Elimination Act (Johanns) repeal of Form 1099 provision; S. 72, Small Business Paperwork Mandate Elimination Act (Baucus) repeal of Form 1099 provision; S. 197, Medical Care Access Protection Act (Ensign) medical liability reform; S. 218, HEALTH Act (Ensign) medical liability reform HCR (Regulatory Issues): HIPAA administrative simplification issues, including standards for privacy, security, electronic transactions and code sets, identifiers, and enforcement; HIPAA enforcement; FEHBP enrollment data clearinghouse initiative; issues relating to health insurance plan participation in FEHBP, including contract requirements related to interoperability of health information technology, community rating policies, and similarly sized subscriber group (SSSG) requirement; implementation of the health savings account provisions of the Medicare Act; issues related to Medicare Secondary Payer requirements; issues related to implementation of the National Health Information Infrastructure, electronic health records, personal health records, and similar technologies; issues relating to market consolidation; issues relating to quality improvement; issues related to potential priority research topics for the effective health care program; issues relating to the national health data stewardship; issues relating to hospital outpatient measurement and reporting; issues related to genetics and genetic nondiscrimination; issues relating to mental health parity; issues relating to data breach requirements; issues relating to "meaningful use" requirements for health information technology; issues regarding application of service provider contract rules; medical loss ratios; review of rates for reasonableness; health insurance exchanges; preexisting condition insurance plans; accountable care organizations; internal claims and appeals and external review processes; coverage of preventive services; pre-existing condition exclusions; lifetime and annual dollar limits on benefits rescissions; patient protections; grandfathered health plan provisions; health insurance web portal requirements; dependent coverage; issues relating to privacy, security, and other regulation of the Internet and electronic commerce, issues relating to the annual fee on health insurance providers; health plan auto-enrollment requirements; and other issues relating to health care reform implementation.

LobbyistCovered position, as disclosed
JEREMY ALLEN New Rep. Bilirakis stf 3/02-6/03, H. E&C stf 6/03-7/04
GARY BACHER —
CARMELLA BOCCHINO —
ELIZABETH BROOKS —
MARY E. DONAHUE —
PAUL EITING —
KAREN IGNAGNI —
ALETHIA JACKSON —
ERIK KOMENDANT New —
SUE ROHAN —
CANDACE SCHALLER —
SCOTT STYLES —
KELLY RENEA VOGEL —
THOMAS JEROME WILDER —

Contacted: Agency for Healthcare Research & Quality (AHRQ); Medicare Payment Advisory Commission (MedPAC); Federal Trade Commission (FTC); Treasury, Dept of; Drug Enforcement Administration (DEA); Health & Human Services, Dept of (HHS); Labor, Dept of (DOL); Centers For Medicare and Medicaid Services (CMS); Office of Personnel Management (OPM); HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); Internal Revenue Service (IRS); Food & Drug Administration (FDA); Social Security Administration (SSA); SENATE

Bills named: H.R. 1 (112th), H.J.Res. 48 (112th), H.R. 4 (112th), S. 218 (112th), H.R. 611 (112th), H.J.Res. 44 (112th), H.R. 5 (112th), S. 18 (112th), S. 197 (112th), S. 72 (112th)

Medicare/Medicaid MMM

H.R. 999, Medicare Prescription Drug Savings and Choice Act (Schakowsky) Medicare Part D changes; H.R. 1063, Strengthening Medicare And Repaying Taxpayers Act (Murphy) Medicare secondary payer rules (cont.) S. 31, Prescription Drug and Health Improvement Act (Franken) Part D price negotiation; S. 44, Medicare Prescription Drug Price Negotiation Act (Klobuchar) Part D price negotiation; S. 560, Medicare Prescription Drug Savings and Choice Act (Durbin) Medicare Part D changes MMM (Regulatory Issues): Ongoing implementation issues for the Medicare Advantage (MA) and Medicare Part D prescription drug programs, including risk adjustment methodology, data, and audit issues, bidding and payment issues (including MA rate assumptions, MA coding intensity, MA Secondary Payer issues, Part D reinsurance, Part D low income subsidies, and audits), application process, audits to evaluate compliance with MA and Part D program rules, benefit design rules, SSA and CMS premium withhold processing issues, enrollment rules, marketing materials review and approval, marketing activities, including conduct and compensation of brokers and agents and plan sponsor marketing staff, measurement and oversight of plan performance including Special Needs Plans (SNPs); quality measures, grievance and appeals processes, fraud and abuse compliance including training, andMedicare/Medicaid integration and contracting issues for Dual Eligible Special Needs Plans (SNPs); Federal preemption of State authority under MA and Part D programs, Part D prescription drug event data reporting, Part D formulary rules, Part D pharmacy access standards, and other operational issues; Medicare creditable drug coverage reporting requirements; implementation issues for the Medicare Retiree Drug Subsidy program; functionality of the Medicare Personal Plan Finder and Drug Plan Finder; National Medicare Education program; ongoing implementation issues for the Medicare cost plan program including enrollment, marketing materials review and approval and other operational issues, MA and Part D systems issues affecting enrollment and disenrollment processing and payment and other operational issues; Medicare demonstration program on performance-based payments for physician groups; physician quality reporting initiative; issues relating to Medicare coverage policy and national coverage decisions; Medicare clinical trials; implementation of MA and Part D changes made in the Accountable Care Act (ACA), including application of the MA STAR system for payment purposes starting 2012 and changes to the Part D coverage gap; Medicaid managed care regulations and policies, including the Medicaid managed care actuarial soundness standard, quality oversight, Medicaid and CHIP Payment and Access Commission (MACPAC), grievance and appeals processes, fraud and abuse compliance, beneficiary information requirements, treatment of Medicaid health plan member hospital days in the upper payment limit calculation; policies affecting State Medicaid funding, including intergovernmental transfers (IGTs), State flexibility, and block grants; coordination of benefits with state Medicaid programs; Medicaid prescription drug cost issues affecting Medicaid health plans; health plan-related Childrens Health Insurance Program (CHIP) issues, including eligibility and outreach issues; implementation of Medicaid changes made in Deficit Reduction Act of 2005, including documentation of citizenship requirements, state benefit flexibility options, and Medicaid managed care organization provider tax issues; standards for electronic prescribing; implementation of Medicaid changes of interest to Medicaid health plans made in the ACA including the managed care organization (MCO) prescription drug rebate provisions; and health information technology standards and policies.

LobbyistCovered position, as disclosed
JEREMY ALLEN New Rep. Bilirakis stf 3/02-6/03, H. E&C stf 6/03-7/04
CARMELLA BOCCHINO —
KAREN IGNAGNI —
ALETHIA JACKSON —
ERIK KOMENDANT New —
JENNIFER RAK —
SUE ROHAN —
CANDACE SCHALLER —
SCOTT STYLES —
KELLY RENEA VOGEL —
HOWARD WEISS —
THOMAS JEROME WILDER —

Contacted: Executive Office of the President (EOP); Food & Drug Administration (FDA); Social Security Administration (SSA); Medicare Payment Advisory Commission (MedPAC); Office of Personnel Management (OPM); Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); Labor, Dept of (DOL); Federal Trade Commission (FTC); Treasury, Dept of; Internal Revenue Service (IRS); Drug Enforcement Administration (DEA); Agency for Healthcare Research & Quality (AHRQ); HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 31 (112th), S. 44 (112th), S. 560 (112th), H.R. 1063 (112th), H.R. 999 (112th)

Insurance INS

H.R. 63, Long-Term Care Insurance Reform Act (Doggett) LTC insurance reforms; H.R. 111, Breast Cancer Patient Protection Act (DeLauro) minimum hospital stays for mastectomy patients (cont.) H.R. 346, Health Care Choice Act (Pearce ) national marketplace for individual coverage; H.R.371, Health Care Choice Act (Blackburn) national marketplace for individual coverage; H.R. 416, Health Insurance Rate Review Act (Schakowsky) rate review; H.R. 1050, Small Business Health Fairness Act (Johnson) association health plans; H.R. 1150, Competitive Health Insurance Reform Act (Gosar) antitrust policy; H.R.1206 -- Access to Professional Health Insurance Advisors Act (Rogers) agent commissions, medical loss ratios; S.137 -- Health Insurance Rate Review Act (Feinstein) rate review; S.159, Confidence in Long-Term Care Insurance Act (Kohl) LTC insurance reforms INS (Regulatory) Insurance regulatory reform; issues related to the coordination of private and public disability income benefits; disability risk management; issues relating to the coordination of benefits between private health insurance plans and Medicaid; Medigap claims processing and crossover fees; implementation of Medigap standardized plan offerings; Medigap carrier recoveries related to CMS fraud and abuse enforcement activities, and issues related to Medigap educational materials; implementation of the Mental Health Parity Act requirements; medical loss ratios; review of rates for reasonableness; health insurance exchanges; pre-existing condition insurance plans; accountable care organizations; internal claims and appeals and external review processes; coverage of preventive services; preexisting condition exclusions; lifetime and annual dollar limits on benefits rescissions; patient protections; grandfathered health plan provisions; health insurance web portal requirements; dependent coverage; and other issues relating to health care reform implementation.

LobbyistCovered position, as disclosed
JEREMY ALLEN New Rep. Bilirakis stf 3/02-6/03, H. E&C stf 6/03-7/04
GARY BACHER —
CARMELLA BOCCHINO —
ELIZABETH BROOKS —
SUSAN CORONEL —
PAUL EITING —
KAREN IGNAGNI —
ALETHIA JACKSON —
ERIK KOMENDANT New —
SUE ROHAN —
CANDACE SCHALLER —
SCOTT STYLES —
KELLY RENEA VOGEL —
THOMAS JEROME WILDER —

Contacted: Internal Revenue Service (IRS); Treasury, Dept of; Food & Drug Administration (FDA); Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; Social Security Administration (SSA); Federal Trade Commission (FTC); Office of Personnel Management (OPM); Health & Human Services, Dept of (HHS); SENATE; Drug Enforcement Administration (DEA); Agency for Healthcare Research & Quality (AHRQ); Labor, Dept of (DOL); Medicare Payment Advisory Commission (MedPAC); Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 1206 (112th), H.R. 111 (112th), S. 137 (112th), H.R. 371 (112th), S. 159 (112th), H.R. 63 (112th), H.R. 416 (112th), H.R. 1050 (112th), H.R. 1150 (112th), H.R. 346 (112th)

Pharmacy PHA

H.R. 979, FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act (Lynch) FEHBP prescription drugs; S. 27, Preserve Access to Affordable Generics Act (Kohl) pay-for-delay settlements PHA (Regulatory): Issues relating to long term safety and effectiveness of medical devices and drugs, including registries; issues relating to post-market surveillance of drugs and medical devices; and issues relating to access for investigational drugs.

LobbyistCovered position, as disclosed
JEREMY ALLEN New —
CARMELLA BOCCHINO —
KAREN IGNAGNI —
ALETHIA JACKSON —
ERIK KOMENDANT New Rep. Bilirakis stf 3/02-6/03, H. E&C stf 6/03-7/04
CANDACE SCHALLER —
SCOTT STYLES —
KELLY RENEA VOGEL —
HOWARD WEISS —

Contacted: Health & Human Services, Dept of (HHS); Labor, Dept of (DOL); Treasury, Dept of; Federal Trade Commission (FTC); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Drug Enforcement Administration (DEA); SENATE; Medicare Payment Advisory Commission (MedPAC); Social Security Administration (SSA); Agency for Healthcare Research & Quality (AHRQ); Office of Personnel Management (OPM); Internal Revenue Service (IRS); Food & Drug Administration (FDA); Executive Office of the President (EOP)

Bills named: H.R. 979 (112th), S. 27 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.